Evaluating an exercise game session in the ExerCube

Evaluating metabolic, hemodynamic and perceptual responses during an exergame session in the ExerCube

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN43067716

Enrollment

Registered

2020-04-14

Start date

2020-04-20

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Other

Interventions

The initial examination begins with the collection of the anthropometric parameters body height, weight, body composition. In addition, an ECG is written, and various hemodynamic parameters are record

Eligibility

Sex/Gender

All

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Young, healthy female and male adults aged 18-35 years 2. Free from acute and chronic diseases, movement restrictions or injuries to the musculoskeletal system

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
1. Oxygen consumption (VO2) (MetMax 3B Cortex): VO2 will be measured during the graded exercise test on the treadmill, and throughout both exercise sessions (ExerCube, moderate endurance exercise training) 2. Peripheral systolic and diastolic blood pressure (Mobil-O-Graph 24 PWA monitor, IEM, Stolberg GERMANY). Blood pressure will be measured before and after the two exercise protocols	—

Secondary

Measure	Time frame
1. Heart rate (Polar Rs800cx, Kempele, Finnland). The heart rate will be measured during the graded exercise test on the treadmill, and throughout both exercise sessions (ExerCube, moderate endurance exercise training) 2. Anthropometric measures (height, weight, waist circumference, body composition) (Tanita BC545N Tokyo, Japan). Weight will be assessed before and after each exercise session. Height, waist circumference and body composition will be measured during the initial examination 3. Physical Activity Enjoyment (Physical Activity Enjoyment Scale). The physical activity enjoyment will be assessed after the exercise session in the ExerCube and after the moderate endurance exercise training 4. Lactate acid (blood sampling from the earlobe). Blood sampling from the earlobe will be taken after each stage of the graded exercise test and before, and after each exercise session 5. Rate of perceived exertion (BORG-RPE-Scale). Subjects are asked to evaluate RPE at each stage of the graded exercise test and at different time points during both exercise sessions 6. Flow-experience (Flow short scale). The flow-experience will be assessed after the exercise session in the ExerCube and after the moderate endurance exercise training	—

Measure

Time frame

1. Heart rate (Polar Rs800cx, Kempele, Finnland). The heart rate will be measured during the graded exercise test on the treadmill, and throughout both exercise sessions (ExerCube, moderate endurance exercise training) 2. Anthropometric measures (height, weight, waist circumference, body composition) (Tanita BC545N Tokyo, Japan). Weight will be assessed before and after each exercise session. Height, waist circumference and body composition will be measured during the initial examination 3. Physical Activity Enjoyment (Physical Activity Enjoyment Scale). The physical activity enjoyment will be assessed after the exercise session in the ExerCube and after the moderate endurance exercise training 4. Lactate acid (blood sampling from the earlobe). Blood sampling from the earlobe will be taken after each stage of the graded exercise test and before, and after each exercise session 5. Rate of perceived exertion (BORG-RPE-Scale). Subjects are asked to evaluate RPE at each stage of the graded exercise test and at different time points during both exercise sessions 6. Flow-experience (Flow short scale). The flow-experience will be assessed after the exercise session in the ExerCube and after the moderate endurance exercise training

—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 27, 2026